17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) Mar 6 - Mar 9, 2024 Supporting Materials Durable Glycemic Control with BMF-219 during Off-Treatment Period at Week 26: A Phase 1/2 Trial of BMF-219 in Patients with Type 2 Diabetes (COVALENT-111) (Poster Discussion Session, March 7th, 10-10:30 am CET.) 407.9 KB Listen to the MP3 recording Key Observations from the Dose Escalation Portion of COVALENT-111, a Phase 1/2 Trial of the Covalent Menin Inhibitor BMF-219 in Patients with Type 2 Diabetes (Poster Viewing Session) 428 KB Listen to the MP3 recording Case Studies from COVALENT-111, A Phase 1/2 Trial of BMF-219, a Covalent Menin Inhibitor, in Patients with Type 2 Diabetes (Poster Viewing Session) 446.3 KB Listen to the MP3 recording Location Florence, Italy
Durable Glycemic Control with BMF-219 during Off-Treatment Period at Week 26: A Phase 1/2 Trial of BMF-219 in Patients with Type 2 Diabetes (COVALENT-111) (Poster Discussion Session, March 7th, 10-10:30 am CET.) 407.9 KB Listen to the MP3 recording
Key Observations from the Dose Escalation Portion of COVALENT-111, a Phase 1/2 Trial of the Covalent Menin Inhibitor BMF-219 in Patients with Type 2 Diabetes (Poster Viewing Session) 428 KB Listen to the MP3 recording
Case Studies from COVALENT-111, A Phase 1/2 Trial of BMF-219, a Covalent Menin Inhibitor, in Patients with Type 2 Diabetes (Poster Viewing Session) 446.3 KB Listen to the MP3 recording
